NASDAQ:SNSS - Sunesis Pharmaceuticals Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$1.28 +0.03 (+2.40 %)
(As of 03/26/2019 06:00 AM ET)
Previous Close$1.25
Today's Range$1.03 - $1.33
52-Week Range$0.20 - $3.08
Volume2.70 million shs
Average Volume831,139 shs
Market Capitalization$86.50 million
P/E Ratio-1.71
Dividend YieldN/A

Analyst Ratings

Sunesis Pharmaceuticals (NASDAQ:SNSS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Sunesis Pharmaceuticals in the last 12 months. Their average twelve-month price target is $3.25, suggesting that the stock has a possible upside of 153.91%. The high price target for SNSS is $6.00 and the low price target for SNSS is $0.50. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.332.002.002.60
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.25$2.25$2.25$4.4933
Price Target Upside: 153.91% upside603.13% upside603.13% upside70.20% upside

Sunesis Pharmaceuticals (NASDAQ:SNSS) Consensus Price Target History

Price Target History for Sunesis Pharmaceuticals (NASDAQ:SNSS)

Sunesis Pharmaceuticals (NASDAQ:SNSS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/12/2019HC WainwrightReiterated RatingHold$0.50LowView Rating Details
3/8/2019OppenheimerSet Price TargetBuy$6.00LowView Rating Details
5/8/2018CowenReiterated RatingHoldHighView Rating Details
3/8/2018Cantor FitzgeraldReiterated RatingHold$4.00HighView Rating Details
12/11/2017Wells Fargo & CoUpgradeMarket Perform ➝ Outperform$2.86 ➝ $2.48HighView Rating Details
11/20/2017UBS GroupInitiated CoverageOutperformN/AView Rating Details
(Data available from 3/26/2017 forward)
This page was last updated on 3/26/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel